Nephros Stock Probability Of Bankruptcy
| NEPH Stock | USD 2.19 0.05 2.34% |
Nephros | Probability Of Bankruptcy |
Nephros Company probability of distress Analysis
Nephros' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Nephros Probability Of Bankruptcy | Over 80% |
Most of Nephros' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nephros is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Nephros probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Nephros odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Nephros financial health.
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 1.371 | Quarterly Revenue Growth 0.272 | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nephros Probability Of Bankruptcy Driver Correlations
Understanding the fundamental principles of building solid financial models for Nephros is extremely important. It helps to project a fair market value of Nephros Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Nephros' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nephros' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nephros' interrelated accounts and indicators.
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
| Competition |
Based on the latest financial disclosure, Nephros has a Probability Of Bankruptcy of 80%. This is 84.8% higher than that of the Household Durables sector and 120.69% higher than that of the Consumer Discretionary industry. The probability of bankruptcy for all United States stocks is 100.85% lower than that of the firm.
Nephros Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nephros' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nephros could also be used in its relative valuation, which is a method of valuing Nephros by comparing valuation metrics of similar companies.Nephros is currently under evaluation in probability of bankruptcy category among related companies.
Nephros Main Bankruptcy Drivers
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Return On Assets | (0.27) | (0.26) | (0.24) | (0.67) | (0.13) | (0.14) | |
| Asset Turnover | 0.89 | 0.46 | 0.59 | 0.91 | 1.2 | 1.26 | |
| Net Debt | (1.6M) | (6.1M) | (5.9M) | (2.5M) | (2.5M) | (2.3M) | |
| Total Current Liabilities | 2.4M | 1.3M | 2.4M | 1.4M | 2.1M | 1.6M | |
| Non Current Liabilities Total | 1.5M | 1.6M | 511K | 706K | 1.4M | 2.0M | |
| Total Assets | 11.6M | 18.5M | 17.7M | 11.0M | 11.9M | 7.5M | |
| Total Current Assets | 8.3M | 15.2M | 13.6M | 8.3M | 8.4M | 6.1M | |
| Total Cash From Operating Activities | (2.3M) | (6.9M) | (1.4M) | (3.2M) | 827K | 868.4K |
Nephros Fundamentals
| Return On Equity | -0.18 | |||
| Return On Asset | -0.0871 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 20.09 M | |||
| Shares Outstanding | 10.54 M | |||
| Shares Owned By Insiders | 11.96 % | |||
| Shares Owned By Institutions | 40.28 % | |||
| Number Of Shares Shorted | 2.56 K | |||
| Price To Earning | (4.51) X | |||
| Price To Book | 2.52 X | |||
| Price To Sales | 1.48 X | |||
| Revenue | 14.24 M | |||
| Gross Profit | 4.73 M | |||
| EBITDA | (1.38 M) | |||
| Net Income | (1.57 M) | |||
| Cash And Equivalents | 4.18 M | |||
| Cash Per Share | 0.41 X | |||
| Total Debt | 1.84 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 5.27 X | |||
| Book Value Per Share | 0.79 X | |||
| Cash Flow From Operations | 827 K | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | (0.15) X | |||
| Target Price | 4.75 | |||
| Number Of Employees | 31 | |||
| Beta | 1.26 | |||
| Market Capitalization | 22.56 M | |||
| Total Asset | 11.86 M | |||
| Retained Earnings | (144.41 M) | |||
| Working Capital | 6.29 M | |||
| Current Asset | 1.53 M | |||
| Current Liabilities | 684 K | |||
| Net Asset | 11.86 M |
About Nephros Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nephros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nephros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nephros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nephros Piotroski F Score and Nephros Altman Z Score analysis. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Nephros Stock analysis
When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 1.371 | Quarterly Revenue Growth 0.272 | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.